Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 12, 2010

View Archived Issues

Basilea Pharmaceutica claims new antibacterial agents

Avexa and Shanghai TargetDrug describe new NS5B inhibitors

Orchid Chemicals & Pharmaceuticals discovers new PDE4 inhibitors

Hybrigenics presents new USP7 inhibitors

German scientists disclose new antiarrhythmic agents

Algeta begins phase I/IIa trial of Alpharadin/docetaxel combination in CRPC

Herceptin approved in Canada for HER2-positive stomach cancer

Epitherix identifies novel chemical scaffolds targeting Wnt pathway

Karo Bio to present phase III development plan for eprotirome in high-risk HeFH

Carbamazepine enhances autophagy and decreases hepatic fibrosis in vivo

Serum uric acid level is a biomarker for new-onset diabetes

Scientists select new H3 receptor antagonists as clinical candidates for sleep disorders

Scientists identify potential susceptibility loci for endometriosis

Midbrain [18F]-fallypride PET can reveal impulsivity in individuals

Dr. Reddy's launches biosimilar darbepoetin alfa for anemia in India

Crucell, IAVI and BIDMC to conduct phase I AdVac-based AIDS vaccine trial

D-Pharm reports results from DP-b99 cardiac safety study

FDA approves NovoSeven RT 8-mg vial for hemophilia A and B

FDA clears Curemark's IND for CM-4612 in ADHD

Healthpoint advances Collagenase Santyl for diabetes-associated foot ulcers

Pathway Therapeutics raises funds for PI3K inhibitor development

Trigemina reports phase IIa data on TI-001 in chronic daily headache

ACT and Brown Cancer Center collaborate to identify cancer therapeutics

Biotest reports final data from phase IIa trial of BT-061 in RA

Biotest updates development program for BT-062 in multiple myeloma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...